WithdrawnPHASE1, PHASE2NCT00562185

Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer

Studying Gonadal germ cell tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Texas Southwestern Medical Center
Principal Investigator
Jayanthi S. Lea, MD
Simmons Cancer Center
Intervention
carboplatin(drug)
Eligibility
18-120 years · FEMALE
Timeline
2008 – 2009

Study locations (1)

Collaborators

Ortho Biotech Clinical Affairs, L.L.C.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00562185 on ClinicalTrials.gov

Other trials for Gonadal germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Gonadal germ cell tumor →

← Back to all trials